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The management strategy for the treatment of
intracranial aneurysms differs significantly between the
patients with ruptured aneurysms and those with
unruptured aneurysms. Ruptured aneurysms should be
treated urgently (within 72 h of bleeding) to prevent
rerupture. After the results of the International
Subarachnoid Aneurysm Trial (ISAT) study were
released, endovascular coiling has becoming increas-
ingly common for the treatment of intracranial ruptured
aneurysms over the past decade. The best management
for the unruptured intracranial aneurysms remains
unclear to date. Randomized controlled trial (RCT) is
one of the most powerful tools to provide the best
evidence for making clinical decisions. Unfortunately,
there is scarce RCT evidence on the management of
intracranial aneurysms. The goal of this article is to
provide a brief review on RCT for the treatment of
intracranial ruptured or unruptured aneurysms.
Randomized Controlled Trials for Ruptured
Intracranial Aneurysms
Endovascular occlusion with detachable platinum
coils has become an established treatment for
managing patients who have ruptured intracranial
aneurysms (1-3). Although numerous studies regard-
ing endovascular or surgical treatment for ruptured
intracranial aneurysms have been reported in the litera-
ture, there are only two randomized, prospective
studies comparing endovascular coiling and surgical
clipping to date (4-6).  
The results of the first, prospective randomized trial
from Finland compared endovascular and surgical
treatment of ruptured intracranial aneurysms was
published in 1999 and 2000 (4, 5). The study included
109 patients with acute (< 72 hours) aneurysmal
subarachnoid hemorrhage who were suitable for both
endovascular coiling and surgical clipping. Aneurysms
were considered suitable for both coiling and clipping
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Endovascular coiling has become the primary treatment modality for the treatment of intracranial
ruptured aneurysms in many centers. A multicenter randomized controlled trial (RCT), ISAT study, has
demonstrated that endovascular coiling of ruptured intracranial aneurysms has benefits over surgical
clipping in those patients suitable for either treatment. Because RCT comparing conservative manage-
ment with surgical clipping and with endovascular coiling have not been performed to date for unrup-
tured intracranial aneurysms, the best management for unruptured aneurysm remains unclear. A RCT is
ongoing to answer the question whether active treatment can improve the outcome of patients with
unruptured intracranial aneurysms as compared with observation. 
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DOI: 10.5469/neuroint.2011.6.1.1if: 1) the neck of the aneurysm was smaller than the
fundus; 2) it was not a fusiform aneurysm; 3) the neck
of the aneurysm and relationship to the parent vessel
was distinguishable; and 4) the diameter of the
aneurysm was bigger than the smallest coil, or 2 mm,
resulting in approximately half of the patients with
aneurysmal subarachnoid hemorrhage suitable for
randomization. The study assessed the angiographic
outcome and clinical outcome at 3 and 12 months. As
an immediate postembolization angiographic result,
posterior circulation aneurysms showed more complete
occlusion with coiling than with surgery (p = 0.045),
whereas anterior circulation (anterior cerebral artery,
anterior communicating aneurysm, and pericallosal
artery) aneurysms showed the better angiographic
outcome with surgical clipping than with endovascular
coiling (p = 0.005). The procedure-related mortality
rate was 2% in the endovascular group and 4% in the
surgical group. One patient had early rebleeding after
incomplete coil embolization. At 12 months, the
clinical outcome did not significantly differ between
two groups, as 79% of endovascular versus 75% of
surgical patients had good or moderate recovery on
Glasgow outcome scale (p = 0.3). As 12-month
angiographic results, 76.9% of the endovascular group
showed total obliteration of the aneurysm, whereas
86.0% of the surgical group showed total obliteration,
which was not statistically significant. The authors
concluded that the clinical outcome at 3 and 12 months
was comparable after endovascular and surgical
treatment of ruptured intracranial aneurysms.
ISAT was a randomized, multicenter trial compared
surgical clipping with endovascular coiling in patients
with ruptured intracranial aneurysms (6-8). Between
1994 and 2002, 2143 patients were enrolled in the
study from 43 neurosurgical centers, most in the United
Kingdom and Europe. The primary objective of the
ISAT was to determine whether there was a reduction
in the proportion of patients who were dead or
dependent (defined as modified Rankin Scale, mRS 3-
6) at 1 year by following a coiling strategy compared
with a clipping strategy. Recruitment of patients was
stopped after an interim analysis showed a benefit of
endovascular treatment on the primary outcome at 1
year. The complete 1-year data from ISAT was
published in The Lancet in 2005 (7). Two-hundred-fifty
of 1,063 (23.5%) patients allocated to endovascular
coiling were dead or dependent at 1 year, compared
with 326 of 1,055 (30.9%) patients allocated to surgical
clipping: an absolute risk reduction of 7.4% (95% CI
3.6% to 11.2%, p = 0.0019). The early survival
advantage in the coiled group was maintained for up to
7 years and was statistically significant (log rank p =
0.03).The risk of epilepsy was substantially lower with
endovascular coiling than with clipping: relative risk
0.52 (95% CI 0.37 to 0.74). There was no significant
difference in the frequency of rebleeding between the
groups (log rank p = 0.22). The rebleeding risk after 1
year in the coiled group is approximately 0.2% per
patient year with follow-up from 1 to 8 years with a
mean of 4 years. ISAT concluded that endovascular
coiling of ruptured intracranial aneurysms, when a
patient is in good clinical grade and the aneurysm
anatomy is suitable for endovascular treatment, is more
likely than neurosurgical treatment to lead to indepen-
dent survival at l year. Since the 1-year results of ISAT
study were released, treatment of patients with a
ruptured intracranial aneurysm has changed signifi-
cantly over the past decade. In many centers, coiling
has become the mainstay of treatment of ruptured
intracranial aneurysms when both coiling and clipping
are considered suitable.
The long-term follow-up results of ISAT were
published in The Lancet Neurology in 2009 (8). At 5
years, the proportion of independent survivors did not
differ between the two groups. Six-hundred-twenty-six
of 755 (83%) patients treated by endovascular coiling
were independent at 1 year, compared with 584 of 713
(82%) patients treated by surgical clipping. However,
the risk of death was still significantly lower in the
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Table 1. Clinical Outcome at 1-Year and 5-Year in the International Subarachnoid Aneurysm Trials (ISAT)
1-Year Outcome 5-Years Outcome
Endovascular Neurosurgery Endovascular Neurosurgery
mRS 0-2 76.5% 69.1% 83% 82%
mRS 3-6 23.5% 30.9% 17% 18%
Absolute risk reduction in % death/dependency 7.4% 1%
Case fatality 8.0% 9.9% 11% 14%
Number of rebleeding from target aneurysm 45% 39% 10% 3%
mRS: modified Rankin scalecoiling group than in the clipping group (relative risk
0.77, 95% CI 0.61-0.98; p = 0.03). At 5 years, 112 of
1,046 (11%) patients in the coiling group have died,
compared with 144 of 1,041 (14%) patients in the
clipping group (log rank, p = 0.03). The annual risk of
the treated aneurysm rebleeding is higher in the
patients treated by the coiling than in those treated by
the clipping: 10 rebleeding occurred in the coiling
group and 3 in the clipping group. However, the risk
remains low and is at a similar level to the risk of
further subarachnoid hemorrhage (SAH) from another
source, either a pre-existing aneurysm or a newly
formed aneurysm. The main finding of the study is that
rates of independence become essentially equivalent at
5 years, whereas mortality rates still favor the patients
treated by endovascular coiling. The major contribution
to the achievement of equivalent long-term functional
outcomes might be the continuing improvement in the
neurological function of less severely disabled patients
in the clipping group between year 2 and year 5. Table
1 summarizes the 1-year and 5-year clinical outcomes
of ISAT study. In summary, ISAT has demonstrated
that endovascular coiling of ruptured intracranial
aneurysms has benefits over surgical clipping in those
patients suitable for either treatment, but this difference
decreases over time (9).  
Randomized Controlled Trials for Unruptured
Intracranial Aneurysms
With the significant advances in the imaging
techniques and widespread use of noninvasive intracra-
nial imaging studies such as CT or MR angiography,
the incidental detection of unruptured intracranial
aneurysm (UIA) has increased greatly. The manage-
ment of patients with UIAs becomes an important
public health issue, but still remains a controversial
topic. There has been no published randomized,
controlled trial with regard to compare natural history
and coiling or clipping, or clipping and coiling for the
management of patients with UIAs, but one such trial is
currently ongoing.
The natural history of UIA remains uncertain.
International Study of Unruptured Intracranial
Aneurysms (ISUIA) is the largest natural history study
of UIA (10,11). A prospective cohort study from
ISUIA showed that the 5-year cumulative rupture risk
of UIAs smaller than 7 mm in the anterior circulation
with no history of SAH to be 0% and that with a
history of SAH 1.5% (11). Aneurysms at posterior
circulations (basilar tip and the posterior communicat-
ing artery), aneurysms larger than 10 mm, and
aneurysms that are found in patients who had bled from
a prior aneurysm were found to have higher risks
(about 0.5% per year). These rupture rates were
somewhat lower than previous estimates. Table 2
shows the 5-year cumulative rupture rates of UIA
among patients in the unopearated prospective cohort
of ISUIA. ISUIA data provided the first, international
prospective data set, but there have been many
criticisms of the ISUIA study, especially with regard to
patient selection bias. Detailed discussion about these
criticisms is out of range for this review and is well
described elsewhere.  
It is generally believed that the risk of rupture for a
UIA is approximately 1% per year for lesions 7-10
mm in diameter (12, 13). In a single-center, observa-
tional study published in 2009, Ishibashi et al. reported
that the annual rupture rate for 529 UIAs was 1.4%
during mean follow-up period of 905.3 days (14). In
their study, a previous history of SAH (the hazard ratio
7.3; 95% CI, 2.5 to 21.2), posterior circulation
aneurysm (the hazard ratio 2.9; 95% CI, 1.1 to 8), and
large size were significant independent predictors for
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Table 2. 5-Year Cumulative Rupture Rates According to Size and Location of Unruptured Aneurysm and According to Patient Group,
Among Patients in the Unoperated Cohort of ISUIA
Aneurysm Size / Group
Aneurysm Location
< 7 mm Group 1* < 7 mm Group 2
� 7-12 mm 13-24 mm 25+ mm
Cavernous (n = 210) 0% 0% 0% 03.0% 6.4%
AC/MC/IC (n = 1037) 0% 1.5% 2.6% 14.5% 40%
Post-P comm. (n = 445) 2.5% 3.4% 14.5% 18.4% 50%
AC, anterior communicating or anterior cerebral artery; Cavernous, cavernous carotid artery; IC, internal carotid artery (not cavernous
carotid artery); MC, middle cerebral artery; Post-P comm, vertebrobasilar, posterior cerebral artery system, or the posterior communicat-
ing artery.
* Patients in group 1 had no history of subarachnoid hemorrhage.
� Patients in group 2 had a history of subarachnoid hemorrhage from a separate aneurysm.aneurysm rupture. The hazard ratio in the large sized (>
10 mm) and giant (> 25 mm) aneurysm were 12.3 and
50 compared with that for small sized (< 5 mm) UIAs.
More recently, a prospective multi-center, observa-
tional study to determine the optimal management for
small UIAs has been published by Japanese group (15).
In that study, 448 UIAs < 5 mm in size have been
followed up for a mean of 41 months. The annual
rupture rate for small UIAs smaller than 5mm is quite
low: 0.54% overall, 0.34% for single aneurysms, and
0.95% for multiple aneurysms. Patient < 50 years of
age, aneurysm diameter of > 4 mm, hypertension, and
aneurysm multiplicity were found to be significant
predictive factors for rupture of small UIAs. Other
reported risk factors for rupture of UIAs in the litera-
ture include cigarette smoking and female sex.  
Endovascular coiling of UIAs can be performed with
relative safety. A recently published systematic review
and meta-analysis found an overall risk of poor
outcomes (mRS 3-6) is in the range of 4-5% after
endovascular coiling in patients with UIA (16).
Recurrence rate is high: 24.4% of the patients followed
up for 0.4-3.2 years. The annual risk of bleeding per
patient-year after endovascular coiling was 0.2%, but
the lack of systematic follow-up, short observation
periods, and missing data hampered the assessment of
clinical efficacy of endovascular coiling (16).  
A RCT is ongoing to answer the question whether
active treatment can improve the outcome of patients
with UIA as compared with observation. TEAM trial
(Trial on Endovascular Aneurysm Management) is an
international, randomized, multicenter, controlled trial
comparing endovascular treatment versus conservative
management of UIAs (17). Primary endpoint is mortal-
ity and morbidity (mRS 3-6) from intracranial
hemorrhage or treatment. Secondary endpoints include
incidence of hemorrhagic events, morbidity related to
endovascular coiling, morphological results, overall
clinical outcome and quality of life. The study will be
conducted in 60 international centers and will enroll
2,002 patients equally divided between the two groups.
The duration of the study is 14 years, the first three
years being for patient recruitment plus a minimum of
10 years of follow-up. The study investigators are
currently enrolling participating centers and patients.  
Preventive treatment with coiling or clipping in
patients with UIA can be justified when the benefits
outweigh the risks of such treatments, with strong
evidence supported by valid data. Currently, in the
absence of randomized controlled studies, any
proposed treatment algorithms for UIAs remain invalid
(16, 17).  
In conclusions, short-term results of ISAT study
showed that endovascular coiling of ruptured intracra-
nial aneurysms, when a patient is in good clinical grade
and the aneurysm anatomy is suitable for endovascular
treatment, is more likely than neurosurgical treatment
to lead to independent survival at l year. Long-term
follow-up results of ISAT study showed that rates of
independence become essentially equivalent at 5 years,
whereas mortality rates still favor the patients treated
by endovascular coiling. Thus, ISAT study has
demonstrated that endovascular coiling of ruptured
intracranial aneurysms has benefits over surgical
clipping in those patients suitable for either treatment,
but this difference decreases over time.
Because RCT comparing conservative management
with surgical clipping and with endovascular coiling
have not been performed to date for unruptured
intracranial aneurysms, the best management for UIAs
remains unclear. A RCT is ongoing to answer the
question whether active treatment can improve the
outcome of patients with UIA as compared with
observation.
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